Carcinoma in situ, bladder

CD2_INSITU_BLADDER_EXALLC

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data
1. Apply sex-specific rule None	-
2. Check conditions not C3_BLADDER	-
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D09.0& Hospital discharge: ICD-9 — 2337 Cause of death: ICD-10 — D09.0& Cause of death: ICD-9 — 2337 Cancer registry: Topography ICD-O-3 — C67 Cancer registry: Morphology ICD-O-3 — ANY Cancer registry: Behaviour codes — 2 3 out of 7 registries used, show all original rules.	-
4. Check minimum number of events None	-
5. Include endpoints None	-
6. Filter based on genotype QC (FinnGen only) None	-

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF9
Parent code in ICD-10: D09

NAME	CD2_INSITU_BLADDER_EXALLC
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS	!C3_BLADDER
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D090
HD_ICD_9	2337
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D090
COD_ICD_9	2337
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO	C67
CANC_TOPO_EXCL
CANC_MORPH	ANY
CANC_MORPH_EXCL
CANC_BEHAV	2

Similar endpoints

↥

List of similar endpoints to Carcinoma in situ, bladder based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Carcinoma in situ, bladder

Case counts by codes

↥

FinnGen case counts by registry codes:

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	4595	913	3669
Only index persons	4430	880	3550
Unadjusted period prevalence (%)
Whole population	0.09	0.03	0.10
Only index persons	0.12	0.03	0.14
Median age at first event (years)
Whole population	72.42	72.37	72.44
Only index persons	72.33	72.15	72.38

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1071	200	871
Unadjusted period prevalence (%)	0.33	0.07	0.38
Median age at first event (years)	71.53	68.62	72.20

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
990: Matched controls
9900

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D41.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bladder

682.8

323.0

577

8130/2-C67.9

ICD-O-3

Papillary urothelial carcinoma, non-invasive of bladder, NOS

+∞

323.0

711

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

+∞

323.0

406

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

3253.8

323.0

493

KCD02

NOMESCO Finland

Transurethral resection of bladder

1312.9

323.0

660

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

323.0

634

UKC02

NOMESCO Finland

Cystoscopy

367.1

323.0

971

1198

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

+∞

316.0

286

UKC05

NOMESCO Finland

Cystoscopy and bladder biopsy

211.4

298.2

297

R31

ICD-10 Finland

Unspecified haematuria

16.4

293.4

551

703

C61

ICD-10 Finland

Malignant neoplasm of prostate

364.8

182.7

179

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

2096.3

178.7

168

ZX136

NOMESCO Finland

Intravesicalis

191.3

170.7

174

KCD32

NOMESCO Finland

Cystoscopic destruction of tumour of bladder

129.7

154.4

163

8120/2-C67.9

ICD-O-3

Urothelial carcinoma in situ of bladder, NOS

+∞

138.8

130

KH1CD

NOMESCO Finland

Very extensive urinary tract ultrasound examination

51.4

123.9

149

WX320

NOMESCO Finland

Spinalanesthesy

5.0

108.6

464

1487

XKD00

NOMESCO Finland

Uroflowmetry

5.0

106.8

446

1388

130

Kela drug reimbursment

Malignant tumour

+∞

100.7

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

5.0

93.4

371

1062

116

Kela drug reimbursment

Prostate cancer

+∞

85.7

WX408

NOMESCO Finland

General anesthesy, balanced

4.3

84.9

411

1407

8130/2-C67.2

ICD-O-3

Papillary urothelial carcinoma, non-invasive of lateral wall of bladder

+∞

82.4

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

7.1

72.1

192

325

TKW99

NOMESCO Finland

Other minor surgical procedure in urology

62.8

69.9

U06

ICPC

Haematuria

14.3

69.4

121

TKC20

NOMESCO Finland

Catheterisation of bladder

5.9

67.4

207

421

WC305

NOMESCO Finland

Simple therapy of local tumor recidive with biomodifiers

692.3

66.7

KCW96

NOMESCO Finland

Other operations on bladder

57.8

63.9

KH1BD

NOMESCO Finland

Extensive urinary tract CT examination

31.4

60.8

L02AE02

ATC

leuprorelin; implant, parenteral

208.7

57.7

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

148.1

53.4

JN4AD

NOMESCO Finland

Body CT examination

7.8

52.4

127

183

WX402

NOMESCO Finland

General anaesthesia

4.2

52.2

225

645

WF002

NOMESCO Finland

Radical radiotherapy

98.8

51.4

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

61.4

50.0

C67

ICD-10 Finland

Malignant neoplasm of bladder

+∞

49.4

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

48.3

WC105

NOMESCO Finland

Simple cytostatic therapy of local tumor recidive

+∞

48.3

A04AA02

ATC

granisetron; systemic, transdermal

175.2

48.3

WX224

NOMESCO Finland

Blockade of obturius nerve

+∞

47.2

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

167.8

46.2

WX404

NOMESCO Finland

Intravenous generell anesthesy

3.5

45.9

247

848

J01MA02

ATC

ciprofloxacin; systemic

2.6

45.6

505

2790

JN4BD

NOMESCO Finland

Extensive body CT

5.7

44.4

136

268

ZXC20

NOMESCO Finland

Use of chemical agents

14.9

44.3

H02AB02

ATC

dexamethasone; systemic

19.1

44.2

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

43.0

A03FA01

ATC

metoclopramide; systemic, rectal

4.4

42.9

172

453

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

+∞

42.0

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

3.5

39.1

206

686

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

2.8

39.1

317

1423

KH1AD

NOMESCO Finland

CT of urinary organs

7.3

39.0

144

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

109.5

39.0

L02BB03

ATC

bicalutamide; oral

+∞

38.8

UKB02

NOMESCO Finland

Retrograde ureteroscopy

15.5

38.5

WF049

NOMESCO Finland

Radiotherapy of metastasis

391.6

38.3

KBJ10

NOMESCO Finland

Cutaneous ureteroenterostomy

391.6

38.3

4CX01

NOMESCO Finland

+∞

37.7

ZXE00

NOMESCO Finland

One hour or less

2.4

37.0

444

2470

N30.0

ICD-10 Finland

Acute cystitis

3.8

36.0

169

509

D41.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Renal pelvis

+∞

35.6

D09.0

ICD-10 Finland

Carcinoma in situ: Bladder

+∞

35.6

Y77

ICPC

Malignant neoplasm prostate

98.6

34.9

KCC10

NOMESCO Finland

Cystoprostatectomy

348.3

34.1

ZXC15

NOMESCO Finland

Use of photodynamic technique

19.8

33.8

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

9.1

33.1

WZC30

NOMESCO Finland

Teaching

3.7

32.5

157

482

PJD54

NOMESCO Finland

Block dissection of iliac lymph nodes

+∞

32.5

KCW02

NOMESCO Finland

Lavation of bladder for coagulated blood

14.5

32.4

C67.0

ICD-10 Finland

Malignant neoplasm: Trigone of bladder

+∞

31.4

XX3DW

NOMESCO Finland

Time consuming IT work

5.0

30.4

102

221

C66

ICD-10 Finland

Malignant neoplasm of ureter

+∞

30.4

KC1GB

NOMESCO Finland

Cystography with X-ray

159.7

29.8

U76

ICPC

Malignant neoplasm of bladder

+∞

29.3

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

28.2

G04BD12

ATC

mirabegron; oral

3.1

28.1

168

604

KED22

NOMESCO Finland

Transurethral resection of prostate

3.2

27.8

161

566

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

12.2

27.4

KCB00

NOMESCO Finland

Biopsy of bladder

55.0

27.3

JN4CD

NOMESCO Finland

Very extensive body CT

8.4

27.2

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

27.2

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

5.7

27.2

153

N02BE01

ATC

paracetamol; systemic, rectal

2.5

27.1

846

6912

R33

ICD-10 Finland

Retention of urine

3.0

26.4

173

659

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

95.9

25.8

115

Kela drug reimbursment

Breast cancer

+∞

25.1

ZXE10

NOMESCO Finland

More than one and less than three hours

2.1

24.9

389

2325

C67.4

ICD-10 Finland

Malignant neoplasm: Posterior wall of bladder

256.1

24.8

G04CA02

ATC

tamsulosin; oral

2.0

24.7

444

2810

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

33.0

24.7

Z51.5

ICD-10 Finland

Palliative care

6.8

24.5

ZX090

NOMESCO Finland

Other technic of radiotherapy

+∞

24.0

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

+∞

24.0

J01MA12

ATC

levofloxacin; systemic

2.4

23.8

234

1122

A04AA01

ATC

ondansetron; systemic, rectal

10.7

23.7

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

245.5

23.7

A98

ICPC

Health maint/preventive medicine

3.2

23.7

926

8106

8130/2-C67.6

ICD-O-3

Papillary urothelial carcinoma, non-invasive of ureteric orifice

+∞

23.0

WF003

NOMESCO Finland

Adjuvant radiotherapy

85.4

22.7

308

Kela drug reimbursment

Alprostadil, sildenafil and combination product containing aviptadil and phentolamine

41.1

22.7

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

8.2

22.7

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.6

22.7

187

815

KA1AE

NOMESCO Finland

Kidney ultrasound examination

7.4

22.4

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

4.8

22.0

170

WF004

NOMESCO Finland

Palliative radiotherapy

+∞

21.9

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.9

21.9

490

3325

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

224.6

21.7

WX302

NOMESCO Finland

Thoracal epidural anesthesy

6.8

21.6

NK6AN

NOMESCO Finland

Total body bone isotope imaging

51.2

21.2

C67.1

ICD-10 Finland

Malignant neoplasm: Dome of bladder

+∞

20.9

PJA12

NOMESCO Finland

Sentinel node biopsy

+∞

20.9

KH1DD

NOMESCO Finland

CT urography of urinary organs

78.5

20.7

KDV10

NOMESCO Finland

Internal urethrotomy

7.5

20.7

J01EA01

ATC

trimethoprim; systemic

2.3

20.4

209

1015

JN3AD

NOMESCO Finland

Abdominal CT examination

3.3

20.0

106

346

KEC00

NOMESCO Finland

Retropubic radical prostatectomy

203.7

19.6

UKA02

NOMESCO Finland

Retrograde ureteronephroscopy

32.0

19.3

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

18.8

L01BC06

ATC

capecitabine; oral

+∞

18.8

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

+∞

18.8

C65

ICD-10 Finland

Malignant neoplasm of renal pelvis

+∞

18.8

KE3AT

NOMESCO Finland

Transrectal gold marker implantation in prostate under ultrasound guidance

+∞

18.8

ZX070

NOMESCO Finland

Intensity modified radiotherapy

+∞

18.8

R82.8

ICD-10 Finland

Abnormal findings on cytological and histological examination of urine

101.9

18.6

B02AA02

ATC

tranexamic acid; systemic

3.2

18.5

103

346

ZXD10

NOMESCO Finland

Scheduled procedure

1.9

18.1

381

2475

KBV12

NOMESCO Finland

Transluminal endoscopic removal of stent from ureter

8.4

17.8

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

+∞

17.8

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

+∞

17.8

J01DB01

ATC

cefalexin; oral

1.9

17.7

761

6259

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

96.7

17.6

L02BG04

ATC

letrozole; oral

96.7

17.6

KDV12

NOMESCO Finland

Urethroscopic internal urethrotomy

9.3

17.5

B01AB05

ATC

enoxaparin; parenteral

1.9

16.9

290

1739

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

+∞

16.7

C67.5

ICD-10 Finland

Malignant neoplasm: Bladder neck

+∞

16.7

A04AA55

ATC

palonosetron, combinations; systemic

+∞

16.7

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

+∞

16.7

8130/2-C67.4

ICD-O-3

Papillary urothelial carcinoma, non-invasive of posterior wall of bladder

+∞

16.7

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

91.6

16.6

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

7.1

16.5

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

4.2

16.1

155

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

3.6

15.9

213

SPAT1167

SPAT

Insertion of urinary catheter

3.8

15.7

189

KBH20

NOMESCO Finland

Replantation of ureter

+∞

15.7

KBV10

NOMESCO Finland

Removal of stent from ureter

22.4

15.6

TPH07

NOMESCO Finland

Cathetrisation of artery

2.5

15.4

128

554

KA3EB

NOMESCO Finland

Antegrade pyelography

57.5

14.8

B01AB10

ATC

tinzaparin; parenteral

3.6

14.8

194

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

4.4

14.8

129

KCD30

NOMESCO Finland

Destruction of tumour of bladder

+∞

14.6

KDE20

NOMESCO Finland

Removal of foreign body from urethra

14.4

14.6

L03AA13

ATC

pegfilgrastim; parenteral

152.0

14.5

SPAT1263

SPAT

Sampling

1.7

14.1

413

2915

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

2.2

14.0

155

772

A02BC02

ATC

pantoprazole; systemic

1.7

14.0

603

4749

KH1FT

NOMESCO Finland

Exchange of urinary catheter with radiological guidance

54.1

13.8

C67.3

ICD-10 Finland

Malignant neoplasm: Anterior wall of bladder

+∞

13.6

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

13.6

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

+∞

13.6

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

+∞

13.6

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

+∞

13.6

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

13.6

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

141.7

13.5

D41.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Ureter

141.7

13.5

WX110

NOMESCO Finland

Local anesthesy

1.7

13.3

578

4532

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

4.7

13.1

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

50.6

12.9

ZXC96

NOMESCO Finland

Robot assisted procedure

14.3

12.8

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

+∞

12.5

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

+∞

12.5

KAC21

NOMESCO Finland

Percutaneous endoscopic nephroureterectomy

+∞

12.5

HAC20

NOMESCO Finland

Total mastectomy

+∞

12.5

KBD00

NOMESCO Finland

Partial excision of ureter

+∞

12.5

PJD44

NOMESCO Finland

Excision of iliac lymph nodes

+∞

12.5

8120/2-C67.2

ICD-O-3

Urothelial carcinoma in situ of lateral wall of bladder

+∞

12.5

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

12.5

KA1FN

NOMESCO Finland

Isotope renography

27.0

12.1

SPAT1312

SPAT

General health counselling

1.7

12.0

293

1939

TKE00

NOMESCO Finland

Needle biopsy of prostate

3.4

12.0

178

Z3231

NOMESCO Finland

Registered nurse

1.8

11.9

268

1728

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

47.2

11.9

SPAT1262

SPAT

Handing over of treatment supplies

1.8

11.9

221

1340

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.6

11.7

354

HAB40

NOMESCO Finland

Wedge excision of mammary gland

30.4

11.7

G04BE03

ATC

sildenafil; oral

12.7

11.7

TJF80

NOMESCO Finland

Ostomy education

23.2

11.6

SPAT1153

SPAT

Removal of sutures

1.7

11.6

320

2190

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

+∞

11.5

163

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

11.5

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

+∞

11.5

C67.6

ICD-10 Finland

Malignant neoplasm: Ureteric orifice

+∞

11.5

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

121.3

11.4

ZX080

NOMESCO Finland

Image guided radiotherapy

121.3

11.4

TPH04

NOMESCO Finland

Cathetrisation of vein

1.8

11.4

209

1258

N30.9

ICD-10 Finland

Cystitis, unspecified

3.2

11.3

192

KBV00

NOMESCO Finland

Insertion of stent into ureter

20.3

11.1

G04CA01

ATC

alfuzosin; oral

1.8

11.1

207

1253

S18

ICPC

Laceration/cut

1.6

11.1

416

3082

D30.3

ICD-10 Finland

Benign neoplasm: Bladder

43.8

10.9

WW500

NOMESCO Finland

Blood transfusion

4.6

10.9

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.6

10.8

420

3132

KCV22

NOMESCO Finland

Transluminal endoscopic evacuation of blood clots from bladder

28.3

10.7

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

28.3

10.7

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.3

10.7

105

490

U29

ICPC

Urinary symptom/complaint other

3.9

10.6

110

U07

ICPC

Urine symptom/complaint other

2.7

10.5

292

TKC22

NOMESCO Finland

Catheterisation instruction

4.1

10.5

101

XJH00

NOMESCO Finland

Transanal ultrasonography

2.3

10.5

456

R39.1

ICD-10 Finland

Other difficulties with micturition

3.3

10.4

164

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

+∞

10.4

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

10.4

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

+∞

10.4

KAC20

NOMESCO Finland

Nephroureterectomy

+∞

10.4

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

+∞

10.4

L03AA14

ATC

lipegfilgrastim; parenteral

+∞

10.4

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

+∞

10.4

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

+∞

10.4

N02AA05

ATC

oxycodone; systemic

2.1

10.4

121

614

ZX120

NOMESCO Finland

Intravenous

2.5

10.1

355

L57.0

ICD-10 Finland

Actinic keratosis

2.3

10.0

424

L03AA02

ATC

filgrastim; parenteral

20.2

9.8

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

55.5

9.7

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

+∞

9.4

L02BX02

ATC

degarelix; parenteral

+∞

9.4

L02BX03

ATC

abiraterone; oral

+∞

9.4

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

+∞

9.4

8130/2-C67.8

ICD-O-3

Papillary urothelial carcinoma, non-invasive of overlapping lesion of bladder

+∞

9.4

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

+∞

9.4

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

+∞

9.4

Z08.2

ICD-10 Finland

Follow-up examination after chemotherapy for malignant neoplasm

+∞

9.4

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.5

9.4

306

N40

ICD-10 Finland

Hyperplasia of prostate

1.6

9.3

372

2766

U05

ICPC

Urination problems other

2.6

9.2

275

N35.9

ICD-10 Finland

Urethral stricture, unspecified

5.7

9.1

L02BA01

ATC

tamoxifen; oral

37.0

9.0

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

8.9

235

1566

SPAT1125

SPAT

Stoma care and guidance

5.5

8.9

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

50.4

8.7

G04BD08

ATC

solifenacin; oral

2.2

8.7

387

R93.4

ICD-10 Finland

Abnormal findings on diagnostic imaging of urinary organs

10.1

8.5

G03HA01

ATC

cyproterone; systemic

27.7

8.5

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

+∞

8.3

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

+∞

8.3

8090/3-C44.2

ICD-O-3

Basal cell carcinoma, NOS, of external ear

+∞

8.3

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

+∞

8.3

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

+∞

8.3

TKC00

NOMESCO Finland

Needle biopsy of bladder

+∞

8.3

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

+∞

8.3

L02AE04

ATC

triptorelin; parenteral

+∞

8.3

A04AD12

ATC

aprepitant; systemic

+∞

8.3

L02BB04

ATC

enzalutamide; oral

+∞

8.3

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

+∞

8.3

R86.0

ICD-10 Finland

Abnormal findings in specimens from male genital organs, abnormal level of enzymes

4.7

8.3

ZX112

NOMESCO Finland

Subcutaneous

9.5

8.3

KBV15

NOMESCO Finland

Cystoscopic change of ureteral stent

14.6

8.2

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

4.2

8.1

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.9

8.1

116

639

GD1AD

NOMESCO Finland

Thorax CT examination

2.8

8.0

174

WX400

NOMESCO Finland

Inhalation anesthesy

3.6

8.0

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

7.9

327

2430

TQW99

NOMESCO Finland

Other minor procedure on skin

3.0

7.9

147

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.0

7.9

519

Z71.8

ICD-10 Finland

Other specified counselling

1.7

7.8

180

1154

U01

ICPC

Dysuria/painful urination

2.6

7.8

220

A79

ICPC

Malignancy NOS

45.3

7.7

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

45.3

7.7

UKD02

NOMESCO Finland

Urethroscopy

10.1

7.5

KBB00

NOMESCO Finland

Biopsy of ureter

80.6

7.4

N21.0

ICD-10 Finland

Calculus in bladder

4.4

7.4

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

+∞

7.3

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

7.3

KCC20

NOMESCO Finland

Cystoprostatourethrectomy

+∞

7.3

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

+∞

7.3

352

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

7.3

L01CA04

ATC

vinorelbine; systemic

+∞

7.3

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

+∞

7.3

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

+∞

7.3

KBJ60

NOMESCO Finland

Anastomosis of ureter to urethra with interposition of ileum

+∞

7.3

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

+∞

7.3

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

+∞

7.3

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

+∞

7.3

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

7.3

WX702

NOMESCO Finland

Supraglottic ventilation device

2.6

7.3

196

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.5

7.2

311

2317

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

4.4

7.2

N47

ICD-10 Finland

Redundant prepuce, phimosis and paraphimosis

2.7

7.1

182

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

6.1

7.1

U02

ICPC

Urinary frequency/urgency

1.9

7.1

102

561

HA1AA

NOMESCO Finland

X-ray mammography

4.8

7.0

U99

ICPC

Urinary disease other

7.0

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

4.1

6.9

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

4.8

6.9

KGH10

NOMESCO Finland

Operation for phimosis

2.8

6.8

156

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

6.8

147

927

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

6.7

296

2214

S77

ICPC

Malignant neoplasm of skin

22.7

6.7

J01CA04

ATC

amoxicillin; systemic

1.4

6.6

668

5845

R50.9

ICD-10 Finland

Fever, unspecified

1.8

6.6

113

662

ZXC50

NOMESCO Finland

Cryotherapy

3.4

6.6

Z2221

NOMESCO Finland

Medical doctor

1.5

6.6

226

1601

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

8.8

6.6

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

6.5

383

3029

NK6BQ

NOMESCO Finland

Whole body extensive bone SPET with low dose CT

70.2

6.4

KH1YT

NOMESCO Finland

Percutaneous implantation of endoprothesis with radiological guidance

70.2

6.4

C50.99

ICD-10 Finland

Breast, unspecified

70.2

6.4

C43.52

ICD-10 Finland

Malignant melanoma on the torso: 'superficial spreading' type

70.2

6.4

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

4.7

6.4

WX704

NOMESCO Finland

Intubation

2.2

6.4

291

KE1BG

NOMESCO Finland

MRI of prostate

14.4

6.4

WX600

NOMESCO Finland

Single shot through catheter

14.4

6.4

SPAT1260

SPAT

Consultation of another employee

1.6

6.4

166

1098

WX882

NOMESCO Finland

High dependency care

3.2

6.4

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.9

6.3

517

RD211

NOMESCO Finland

2.5

6.3

189

A06AH03

ATC

naloxegol; oral

11.1

6.3

UJF32

NOMESCO Finland

Coloscopy

1.5

6.3

229

1641

WX290

NOMESCO Finland

Other blockade of nerve

1.5

6.3

286

2151

8070/3-C44.3

ICD-O-3

Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

6.3

8130/2-C67.5

ICD-O-3

Papillary urothelial carcinoma, non-invasive of bladder neck

+∞

6.3

8070/3-C34.3

ICD-O-3

Squamous cell carcinoma, NOS, of lower lobe, lung

+∞

6.3

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

+∞

6.3

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

+∞

6.3

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

+∞

6.3

7323

FHL

Electrosection of TU bladder wall change

+∞

6.3

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

+∞

6.3

4078

NOMESCO Finland

+∞

6.3

SPAT1301

SPAT

No procedures

1.5

6.3

298

2259

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

2.6

6.2

176

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.4

6.2

433

3525

ZXE20

NOMESCO Finland

More than three and less than five hours

1.7

6.2

121

738

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.7

6.1

127

787

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.1

6.1

102

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

6.1

236

1712

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.0

6.1

376

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3002256) Pathology report gross observation

540

594

17.32

307.65

1.9

1.1

—

(3049717) Cytology report of Urine Cyto stain

852

391

102.67

307.65

7.4

1.8

—

(40768804) Tissue Pathology biopsy report

770

2359

9.06

270.65

3.3

1.7

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

861

3208

9.59

239.03

10.1

3.1

—

(3026008) Bacteria identified in Urine by Culture

723

2397

7.21

222.23

6.0

3.0

—

(3000850) Epithelial cells [#/volume] in Urine

602

1865

6.09

193.27

6.7

2.4

e6/l

3.5

3.6

0.08

562

1628

(3002582) Erythrocytes [#/volume] in Urine

691

2661

5.50

164.58

11.4

3.1

e6/l

531.6

114.3

1.57

636

2069

(3030467) Casts [#/volume] in Urine by Automated count

637

2426

5.01

150.12

10.6

3.0

e6/l

0.2

0.5

5.88

561

1836

(3031040) Bacteria [#/volume] in Urine by Automated count

985

5485

10.91

143.00

14.8

4.2

e6/l

55.8

1667.6

0.94

(3018095) Leukocytes [#/volume] in Urine

710

3025

5.00

142.48

12.4

3.5

e6/l

161.0

99.3

0.91

660

2205

(36304419) Bacteria [Presence] in Urine

596

2317

4.55

132.52

10.4

3.0

—

(3026782) Osmolality of Urine

485

1732

4.29

118.35

7.2

2.6

mosm/kgh2o

585.8

565.4

1.53

447

1447

(3037467) Urinalysis macro (dipstick) panel - Urine

974

5806

8.48

117.90

10.1

4.0

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

741

3635

4.37

113.63

5.9

3.8

—

(4035726)

164

258

7.33

102.55

1.4

1.3

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

416

1498

3.91

97.01

9.7

2.7

e6/l

1.0

0.04

347

890

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

393

1378

3.93

94.99

10.7

2.9

e6/l

1.1

1.2

0.19

324

778

(3044640) Blood type and Crossmatch panel - Blood

528

2395

3.38

83.31

3.2

2.3

—

(3021601) Nitrite [Presence] in Urine by Test strip

695

4040

3.05

66.02

8.2

4.7

estimate

0.0

0.00

190

720

(3035350) Ketones [Presence] in Urine by Test strip

696

4056

3.04

65.68

6.4

3.5

estimate

0.0

0.00

191

716

(3009261) Glucose [Presence] in Urine by Test strip

699

4119

3.01

63.94

6.4

3.5

estimate

0.0

0.00

182

687

(3013826) Glucose [Moles/volume] in Serum or Plasma

813

5257

3.27

62.00

5.9

4.7

mmol/l

6.9

7.0

0.62

789

4918

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

178

472

4.32

61.31

3.7

1.4

ug/l

24.7

3.7

0.84

148

358

(3030981) Hyaline casts [#/volume] in Urine by Automated count

175

503

3.96

53.67

8.4

2.6

e6/l

0.2

0.3

1.17

175

496

(3023368) Bacteria identified in Blood by Culture

497

2676

2.60

50.33

5.0

4.2

—

(40761535) Cells panel - Urine sediment

228

818

3.27

49.60

6.7

3.0

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

659

4163

2.52

45.96

7.3

4.0

umol/l

10.7

13.2

11.86

632

3904

(3032080) INR in Blood by Coagulation assay

638

3993

2.48

45.07

12.9

11.9

inr

1.3

1.4

1.78

201

1109

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

373

1863

2.54

42.78

3.3

2.3

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

869

6393

2.90

42.17

9.3

5.5

u/l

78.7

78.0

0.17

824

5879

(3041096) Erythrocytes [Presence] in Urine by Automated

391

2076

2.39

38.44

6.0

3.2

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1007

8237

4.72

37.64

23.9

14.9

mg/l

31.7

26.9

3.75

878

6517

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

967

7799

3.47

34.88

26.0

13.9

ml/min/173m2

70.8

73.8

4.36

885

6314

(40768800) Prostate Pathology biopsy report

101

6.23

34.50

1.2

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

566

3657

2.16

33.17

6.1

3.9

g/l

34.2

35.0

2.65

527

3342

(3019550) Sodium [Moles/volume] in Serum or Plasma

1038

8897

6.41

31.62

29.9

18.3

mmol/l

139.5

139.8

2.75

1022

8636

(3023103) Potassium [Moles/volume] in Serum or Plasma

1038

8916

6.33

31.09

30.2

18.5

mmol/l

4.0

0.52

1021

8645

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

636

4364

2.13

31.07

8.0

5.8

mmol/l

1.2

0.49

528

3674

(3013650) Neutrophils [#/volume] in Blood by Automated count

644

4444

2.13

30.93

9.6

6.0

e9/l

4.6

4.5

0.59

556

3840

(3033658) Prothrombin time (PT) actual/Normal

360

1996

2.21

30.61

4.9

3.7

84.1

80.6

1.68

355

1940

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

500

3153

2.10

30.38

7.2

3.7

—

(3003694) ABO and Rh group [Type] in Blood

356

1996

2.17

29.18

1.4

1.3

—

(40761511) CBC panel - Blood by Automated count

1005

8528

3.90

28.61

24.2

14.6

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

752

5593

2.16

28.54

5.9

4.1

ug/l

2.7

2.8

0.05

673

4987

(40761536) Microorganisms panel - Urine sediment

167

675

2.75

28.34

6.1

3.5

—

(3007461) Platelets [#/volume] in Blood

1043

9126

6.47

27.46

36.7

21.6

e9/l

237.4

231.4

2.30

1019

8806

(3024731) MCV [Entitic volume]

1043

9127

6.46

27.43

36.6

21.6

91.9

0.02

1030

8920

(3035941) MCH [Entitic mass]

1043

9127

6.46

27.43

36.6

21.5

30.4

30.6

3.17

1030

8922

(3026361) Erythrocytes [#/volume] in Blood

1043

9128

6.46

27.40

36.8

21.6

e12/l

4.4

4.5

6.33

1017

8762

(3010813) Leukocytes [#/volume] in Blood

1043

9128

6.46

27.40

36.8

21.6

e9/l

7.2

6.9

6.41

1017

8766

(3000963) Hemoglobin [Mass/volume] in Blood

1043

9130

6.45

27.35

37.0

21.7

g/l

132.7

137.3

15.41

1030

8921

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

581

4005

1.99

26.24

7.2

5.4

mmol/l

1.2

0.66

519

3540

(3014576) Chloride [Moles/volume] in Serum or Plasma

240

1212

2.26

24.97

7.7

6.2

mmol/l

105.2

104.3

2.29

235

1172

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

201

943

2.39

24.81

5.0

3.3

—

(3029937) Albumin [Presence] in Urine by Test strip

378

2306

1.99

23.71

7.3

3.8

estimate

0.0

0.50

171

665

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1013

8855

3.66

22.94

12.9

9.5

u/l

25.3

26.7

1.56

973

8420

(3019069) Monocytes/100 leukocytes in Blood

540

3752

1.89

22.57

6.2

5.8

9.0

9.1

0.22

499

3464

(3002030) Lymphocytes/100 leukocytes in Blood

545

3809

1.88

22.26

6.1

5.6

24.4

25.9

2.25

504

3488

(3006504) Eosinophils/100 leukocytes in Blood

537

3737

1.88

22.22

6.0

5.5

2.7

3.0

2.19

498

3436

(42870588) Differential panel, method unspecified - Blood

425

2753

1.90

21.91

5.1

5.3

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

280

1574

2.05

21.80

2.0

1.8

—

(3022096) Basophils/100 leukocytes in Blood

523

3628

1.86

21.68

6.0

5.5

0.6

0.7

2.58

486

3342

(3013707) Erythrocyte sedimentation rate by Westergren method

786

6230

1.98

21.28

4.3

4.1

mm/h

16.1

12.8

5.16

699

5661

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

407

2623

1.89

21.13

3.2

2.3

u/l

55.5

58.7

1.06

381

2389

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

8.19

20.96

1.5

1.3

—

(3018010) Neutrophils/100 leukocytes in Blood

536

3779

1.84

20.79

5.8

5.5

59.9

58.6

1.56

502

3489

(3044889) 12 lead EKG panel

775

6191

1.91

19.47

5.2

4.4

—

(3013115) Eosinophils [#/volume] in Blood

571

4174

1.79

19.01

5.6

5.3

e9/l

0.2

0.95

493

3636

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

531

3809

1.78

18.78

2.5

2.2

—

(3009542) Hematocrit [Volume Fraction] of Blood

854

7088

2.01

18.61

25.6

16.4

39.3

39.5

0.30

489

4261

(3013512) EKG study

426

2876

1.80

18.42

5.2

4.3

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

170

3.68

18.41

4.4

1.8

u/ml

80.1

44.7

0.26

134

(3011397) Hemoglobin [Presence] in Urine by Test strip

323

2007

1.87

18.27

6.2

3.5

—

(3006315) Basophils [#/volume] in Blood

554

4053

1.76

18.04

5.5

5.2

e9/l

0.0

1.59

470

3478

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

132

589

2.42

17.93

1.9

1.6

—

(3001604) Monocytes [#/volume] in Blood

546

4020

1.73

17.02

5.5

5.2

e9/l

0.7

0.6

0.91

462

3440

(3015377) Calcium [Moles/volume] in Serum or Plasma

393

2639

1.77

16.97

4.1

2.0

mmol/l

2.3

0.18

328

2142

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

144

685

2.27

16.86

4.6

3.4

kpa

5.1

0.23

136

625

(3009343) pH of Capillary blood

142

673

2.28

16.77

4.6

3.4

7.4

0.44

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

360

2375

1.78

16.41

2.6

2.2

mg/l

3.1

3.0

0.47

305

1993

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

137

647

2.28

16.30

4.4

3.4

mmol/l

1.0

1.8

1.57

108

460

(3019198) Lymphocytes [#/volume] in Blood

552

4109

1.71

16.25

5.6

5.3

e9/l

1.9

1.8

0.43

482

3564

(3045414) Leukocytes [Presence] in Urine

333

2.76

16.17

3.6

1.8

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

141

687

2.21

15.54

1.9

2.0

g/l

0.2

2.34

130

613

(3021589) Normoblasts [#/volume] in Blood

488

3543

1.69

15.53

14.3

9.1

e9/l

0.0

0.05

405

2903

(3018418) pH of Serum or Plasma

368

2501

1.72

14.78

4.5

3.3

7.4

0.02

450

(3002385) Erythrocyte distribution width [Ratio]

788

6562

1.76

14.53

31.3

17.8

14.0

13.8

5.51

774

6382

(3022313) Gas panel - Capillary blood

108

489

2.34

14.13

4.9

3.5

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

581

4520

1.62

13.37

5.2

3.9

20.7

24.2

6.98

330

2299

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

946

8409

2.07

13.30

5.7

5.2

mmol/l

6.3

6.2

1.45

816

7497

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

331

2.57

13.23

4.4

2.9

u/ml

0.3

0.12

190

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

4.00

13.06

2.1

1.7

u/ml

455.2

56.4

0.45

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

864

7477

1.80

12.92

4.7

4.1

mu/l

2.0

1.02

735

6628

(3012095) Magnesium [Moles/volume] in Serum or Plasma

215

1295

1.83

12.88

4.0

2.7

mmol/l

0.8

0.61

200

1193

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

424

3095

1.61

12.39

3.5

2.8

ug/l

0.7

0.8

0.14

323

2212

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

195

2.98

12.39

1.5

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

209

1262

1.82

12.38

3.2

2.6

18.8

22.9

4.46

175

1066

(3004789) Transferrin [Mass/volume] in Serum or Plasma

218

1336

1.79

12.28

3.1

2.6

g/l

2.3

2.2

1.27

195

1230

(3035637) Corticotropin [Mass/volume] in Plasma

5.00

12.20

1.5

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

8.93

12.02

1.0

1.1

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

172

995

1.87

11.64

3.2

2.6

u/l

222.7

240.8

2.55

162

926

(3042936) Bacteria identified in Isolate by Culture

209

1291

1.77

11.39

2.0

2.1

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

349

2.40

11.37

3.5

3.0

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

184

1100

1.81

11.18

1.8

—

(3022145) Colonoscopy Study observation

141

777

1.94

11.04

1.4

1.3

—

(3020779) Urea [Moles/volume] in Serum or Plasma

155

889

1.87

10.74

6.8

6.9

mmol/l

10.6

11.5

0.89

146

833

(3003458) Phosphate [Moles/volume] in Serum or Plasma

193

1186

1.77

10.66

6.5

5.5

mmol/l

1.0

0.01

181

1095

(3000991) Gas panel - Venous blood

143

803

1.90

10.57

8.6

7.6

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

368

2.30

10.51

2.2

1.5

—

(3014051) Protein [Presence] in Urine by Test strip

192

2.80

10.38

4.9

2.1

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

604

4907

1.53

10.34

3.2

3.0

u/l

56.1

55.6

0.04

550

4423

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

3.63

10.26

1.2

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

425

3209

1.54

10.19

3.4

2.8

ug/l

159.3

167.5

0.27

373

2906

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

180

1098

1.77

10.17

1.8

1.9

—

(3022948) Iron [Moles/volume] in Serum or Plasma

224

1456

1.68

10.06

3.2

2.5

umol/l

11.1

12.6

2.23

205

1328

(3019225) pH of Specimen

156

924

1.81

9.71

5.9

3.5

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

116

625

1.96

9.68

8.4

8.3

1.2

1.4

0.88

116

619

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

924

8342

1.78

9.65

5.1

5.0

mmol/l

4.2

4.3

2.03

799

7594

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

115

619

1.96

9.62

8.6

8.4

0.5

0.7

3.87

115

612

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

102

527

2.03

9.58

8.6

9.5

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

941

8566

1.81

9.22

5.7

5.6

mmol/l

2.4

2.5

2.87

813

7764

(3000330) Specific gravity of Urine by Test strip

478

2.06

9.22

8.0

3.3

—

(3021960) Folate [Moles/volume] in Serum or Plasma

331

2409

1.54

9.18

1.6

nmol/l

19.1

19.7

0.28

270

2001

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

125

704

1.88

9.13

4.3

3.2

mmol/l

1.2

1.06

105

600

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

142

836

1.81

9.00

2.7

2.5

umol/l

9.0

9.8

0.11

129

726

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

400

2.14

8.96

2.3

1.6

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

694

5900

1.50

8.90

3.9

3.3

pmol/l

15.0

0.02

580

5190

(3022621) pH of Urine by Test strip

110

600

1.93

8.85

4.5

2.8

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

902

8148

1.68

8.66

7.7

6.9

mmol/mol

42.1

41.3

1.51

805

7438

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

911

8268

1.68

8.37

5.0

4.9

mmol/l

1.3

1.4

3.32

782

7470

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

407

3140

1.48

8.37

2.1

nmol/l

79.5

77.5

0.56

335

2697

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

116

660

1.85

8.20

2.6

2.2

u/l

32.2

33.0

0.11

103

541

(40768806) Pleura Pathology biopsy report

3.44

8.11

1.6

1.5

—

(3012516) Albumin [Mass/volume] in Urine

421

3288

1.46

8.05

3.4

3.3

mg/l

210.4

181.0

0.07

297

2188

(3025159) Blasts/100 leukocytes in Blood

106

593

1.87

7.90

4.7

3.7

2.9

0.7

0.34

123

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

416

3254

1.46

7.83

3.4

3.2

ng/l

2518.2

1744.9

1.09

367

2819

(3021901) Oxygen saturation in Capillary blood

210

2.45

7.77

2.4

2.9

—

(3009508) Creatinine [Moles/volume] in Urine

423

3323

1.45

7.77

3.3

mmol/l

7.5

7.9

1.73

331

2747

(3003396) Base excess in Arterial blood by calculation

180

1178

1.63

7.73

7.3

6.8

mmol/l

0.2

1.3

3.52

145

907

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

223

1537

1.57

7.72

4.1

2.1

mmol/l

2.5

2.4

2.63

198

1301

(3027801) Oxygen [Partial pressure] in Arterial blood

180

1180

1.63

7.68

7.2

6.8

kpa

12.0

11.4

0.89

173

1125

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

180

1180

1.63

7.68

7.3

6.8

kpa

5.0

5.1

0.66

174

1125

(40768795) Lymph node Pathology biopsy report

6.73

7.62

1.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

883

8001

1.59

7.60

4.5

4.4

mmol/l

1.4

1.3

3.16

749

7159

(3052851) Hemolysis interference index of Serum or Plasma

257

2.29

7.57

4.1

3.5

—

(40768441) Liver Pathology biopsy report

5.66

7.55

1.2

1.6

—

(3002032) Base excess in Venous blood by calculation

155

983

1.67

7.51

4.2

3.5

mmol/l

1.2

2.0

1.98

118

786

(3015235) Bicarbonate [Moles/volume] in Capillary blood

292

2.19

7.43

3.4

3.3

mmol/l

23.9

24.9

1.04

257

(3017181) Myelocytes/100 leukocytes in Blood

113

659

1.80

7.37

4.8

3.6

0.9

0.8

0.13

162

(3020682) Albumin/Creatinine [Ratio] in Urine

435

3463

1.43

7.32

4.3

4.2

mg/mmol

11.0

7.7

0.59

298

2284

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

261

2.25

7.31

1.6

1.7

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

497

4054

1.42

7.29

2.2

2.1

pmol/l

91.9

92.0

0.02

278

2188

(3009214) Lutropin [Units/volume] in Serum or Plasma

127

2.82

7.28

1.3

u/l

8.9

6.6

0.71

107

(3012501) Base excess in Blood by calculation

211

2.39

7.23

3.5

4.8

mmol/l

2.5

2.9

0.26

133

(1616796) Gas panel - Central venous blood

219

2.35

7.11

2.9

3.9

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

104

599

1.82

7.07

1.6

1.5

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

472

3831

1.41

7.05

5.4

4.1

ng/l

44.4

75.3

1.35

403

2976

(3021440) Promyelocytes/100 leukocytes in Blood

108

632

1.79

6.97

4.5

3.6

0.2

0.1

0.62

147

(3002179) Metamyelocytes/100 leukocytes in Blood

103

595

1.81

6.94

4.6

3.6

0.9

0.5

1.04

117

(3022217) INR in Platelet poor plasma by Coagulation assay

217

1527

1.53

6.77

31.8

30.3

inr

1.4

1.5

0.61

212

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

322

2455

1.45

6.73

3.0

2.7

u/l

46.5

46.9

0.01

295

2312

(3042631) Mycobacterium sp identified in Specimen

127

2.73

6.72

2.9

2.7

—

(3012544) pH of Venous blood

157

1030

1.61

6.64

4.3

3.6

—

7.4

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

111

667

1.74

6.54

2.2

nmol/l

10.1

15.0

9.26

565

(3027945) Reticulocytes/100 erythrocytes in Blood

186

1280

1.55

6.40

2.8

2.0

1.8

1.7

0.12

166

1114

(3026493) Urate [Moles/volume] in Serum or Plasma

326

2512

1.43

6.37

3.1

2.7

umol/l

7148.8

7628.9

0.05

257

2119

(3004809) Band form neutrophils/100 leukocytes in Blood

108

2.83

6.35

3.9

2.9

0.8

1.5

0.58

(40768797) Stomach Pathology biopsy report

164

1106

1.57

6.16

1.3

1.2

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

233

1695

1.48

6.15

1.7

1.6

mg/l

1.6

1.3

0.49

180

1314

(3036481) Cortisol [Moles/volume] in Serum or Plasma

108

661

1.70

5.97

3.6

1.7

nmol/l

350.4

363.9

0.24

102

591

(3007853) Bacteria identified in Skin by Aerobe culture

157

1056

1.57

5.96

1.9

—

(3045424) Erythrocytes [Presence] in Urine

107

2.76

5.89

1.4

—

(3012441) Differential panel - Pleural fluid

2.83

5.76

1.5

—

(40767503) Oxygen content in Capillary blood by calculation

214

2.20

5.73

2.3

2.5

15.6

16.2

0.40

116

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

432

1.84

5.72

2.0

1.7

ug/l

1.2

2.0

0.54

379

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

470

1.81

5.69

4.7

4.0

mmol/l

23.5

24.3

1.42

410

(3006184) Hemoglobin [Mass/volume] in Capillary blood

228

2.11

5.30

1.8

2.3

g/l

124.9

133.0

0.95

168

(40758558) Short blood count panel - Blood

246

1856

1.42

5.28

8.4

4.6

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

587

1.68

5.09

1.6

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

3.70

4.93

1.1

1.2

iu/l

25.1

18.1

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

2.78

4.80

1.1

1.4

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

254

1964

1.38

4.67

4.4

4.1

ng/l

500.7

491.1

0.01

218

1714

(3023520) Reticulocytes [#/volume] in Blood

140

970

1.51

4.64

2.4

2.1

e9/l

62.8

67.9

0.94

110

756

(3051611) Lipemic interference index of Serum or Plasma

2.79

4.63

3.5

3.1

—

(3037121) Protein [Mass/volume] in Urine

305

1.88

4.61

3.2

2.5

g/l

0.4

0.2

0.50

106

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

105

2.51

4.49

1.1

1.0

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

3.07

4.25

1.2

1.3

u/l

12.9

10.9

0.28

(3051651) Icteric interference index of Serum or Plasma

3.29

4.20

3.5

2.9

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

297

1.83

4.02

2.8

3.2

pmol/l

4.3

4.4

0.55

248

(3022806) Fractional oxyhemoglobin in Capillary blood

124

2.29

3.99

2.0

1.7

88.7

89.8

0.42

124

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

2.51

3.98

1.0

1.3

nmol/l

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

500

1.63

3.90

1.6

g/l

1.7

1.5

1.52

417

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

361

3015

1.30

3.84

2.5

2.2

u/l

211.5

265.4

0.41

331

2808

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

326

1.76

3.77

2.2

2.3

ug/min

203.1

96.7

0.37

197

(3026389) Candida sp identified in Specimen by Organism specific culture

2.45

3.65

1.3

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

110

2.30

3.64

1.4

1.5

e6/l

17366.8

78022.6

0.61

(40760892) CBC W Ordered Manual Differential panel - Blood

209

1629

1.35

3.59

5.1

4.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

2.42

3.57

1.7

1.6

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

2.53

3.56

4.7

2.5

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

2.53

3.56

3.2

3.0

63.0

57.7

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

473

1.61

3.53

2.7

2.4

—

(3012565) Volume of 24 hour Urine

3.20

3.50

1.5

2.5

1712.9

2114.9

—

(3000494) Fungus identified in Specimen by Culture

136

991

1.43

3.50

1.4

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

174

1.99

3.42

2.4

2.2

219.8

199.9

0.58

164

(3008757) Leukocyte morphology finding [Identifier] in Blood

2.47

3.39

5.7

3.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

7.04

3.36

1.0

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

267

2183

1.30

3.26

1.8

1.7

pmol/l

431.2

24301611.3

1.72

201

1753

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

4.77

3.24

5.9

1.4

nmol/l

78.4

69.1

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

106

750

1.46

3.20

3.4

2.4

ml/min/173m2

55.8

61.7

0.87

308

(3035320) C reactive protein [Mass/volume] in Body fluid

2.88

3.20

1.9

2.7

—

(3037756) Immunofixation for Serum or Plasma

174

1.93

3.07

1.3

1.2

—

(3019150) Specific gravity of Urine by Refractometry

239

1942

1.30

3.04

8.1

3.9

kg/l

1.0

0.15

300

(3021387) Prolactin [Units/volume] in Serum or Plasma

106

2.20

3.04

1.5

1.9

mu/l

321.1

268.9

0.21

(3000492) Spirometry study

640

1.48

3.03

1.6

1.5

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

222

1.79

2.89

1.2

1.5

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

6.70

2.87

1.3

1.1

—

(3017732) Neutrophils [#/volume] in Blood

549

1.49

2.83

3.1

3.4

e9/l

4.5

4.2

0.37

374

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

209

1.80

2.81

1.3

1.4

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

209

1.80

2.81

1.3

1.4

—

(40768443) Skin Pathology biopsy report

324

1.64

2.80

1.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

4.47

2.80

1.1

1.3

—

(3023199) Leukocytes [#/volume] in Pleural fluid

118

2.06

2.73

1.5

e6/l

1428.4

1843.2

0.29

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

3.77

2.67

2.3

2.0

—

(3019309) Folate [Moles/volume] in Red Blood Cells

251

2087

1.26

2.64

1.9

1.8

nmol/l

1120.5

1143.0

0.14

173

1570

(1761482) Bacteria [#/volume] in Urine by Culture

261

1.67

2.57

11.2

3.8

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

180

1.80

2.49

1.5

1.7

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

2.34

2.49

1.3

1.5

—

(3043410) Blood group antigens tested for on Red Blood Cells

3.83

2.46

2.1

1.3

—

(3035285) Chloride [Moles/volume] in Venous blood

131

1.93

2.42

2.4

2.1

mmol/l

107.0

105.3

1.01

131

(3041354) Potassium [Moles/volume] in Venous blood

131

1.93

2.42

2.4

2.1

mmol/l

4.2

4.1

0.15

131

(3036782) Glucose [Moles/volume] in Pleural fluid

2.19

2.42

1.6

1.5

mmol/l

7.3

7.0

0.21

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

2.36

2.39

2.3

1.5

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

3.66

2.36

5.4

3.0

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

2.47

2.28

1.2

1.1

—

(1761868) Lipid panel - Serum or Plasma

285

2443

1.23

2.26

3.7

3.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

2.52

2.19

1.2

1.5

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

2.52

2.19

1.2

1.5

—

(40760888) Immunoglobulin light chains.free panel - Serum

236

1.63

2.13

2.7

1.5

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

2.38

2.12

1.2

1.4

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

619

1.39

2.09

1.9

1.5

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

154

1.77

2.05

1.6

1.4

—

(21494814) CD8 cells/100 lymphocytes in Specimen

4.02

2.04

1.5

4.7

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

125

1.86

2.03

1.6

1.3

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

1.98

2.01

1.1

1.3

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

126

1.84

1.99

2.5

2.2

—

(40757373) Influenza virus identified in Isolate

3.35

1.96

2.6

1.4

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

314

1.52

1.96

4.2

1.5

mg/l

89.7

36.5

0.99

253

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

306

1.53

1.96

4.3

1.5

ratio

1.1

1.3

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

4.56

1.94

1.0

3.3

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

4.56

1.94

2.6

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

356

1.48

1.94

1.4

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

602

1.37

1.94

1.9

1.6

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

315

1.51

1.94

4.2

1.5

mg/l

50.4

53.4

0.15

252

(4281824)

2.74

1.93

1.3

1.2

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

188

1.67

1.92

1.7

1.4

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

2.07

1.91

1.1

1.3

—

(3014271) Vancomycin [Susceptibility]

2.26

1.91

3.2

2.9

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

151

1231

1.26

1.88

5.0

5.1

32.8

32.7

0.06

803

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

115

1.84

1.83

1.0

1.2

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

4.18

1.82

2.6

2.5

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

131

1054

1.28

1.82

2.8

2.5

ug/l

6.5

8.2

0.60

115

914

(3045142) Bone marrow Pathology biopsy report

2.10

1.76

1.0

1.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

3.35

1.75

1.5

1.2

—

(3003338) MCHC [Mass/volume]

708

6682

1.18

1.74

33.2

19.9

g/l

331.0

333.0

6.51

700

6631

(3000570) Elastase.pancreatic [Mass/mass] in Stool

202

1.60

1.73

1.4

1.5

ug/g

238.6

275.7

0.48

127

(40768793) Breast Pathology biopsy report

2.68

1.72

1.6

1.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

118

1.80

1.71

1.7

1.5

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

196

1.60

1.67

1.8

1.4

—

(3045788) Cell count panel - Pleural fluid

1.87

1.66

1.3

1.6

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

3.17

1.66

1.2

1.5

35.3

29.9

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

2.81

1.65

3.3

2.0

ug/l

44.0

56.7

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

127

1.75

1.65

3.6

3.7

—

(4024509)

1.99

1.65

1.4

1.6

—

(4034850)

327

0.57

1.63

17.3

11.9

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.51

1.60

2.4

1.1

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

136

1.71

1.59

1.9

1.5

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

248

1.51

1.57

1.2

1.3

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

268

2359

1.18

1.57

1.6

mmol/l

1.4

1.3

0.87

204

1919

(3024891) Influenza virus A+B Ag [Presence] in Specimen

176

1.61

1.56

1.1

1.2

—

(3008037) Lactate [Moles/volume] in Venous blood

249

1.50

1.54

3.8

2.9

mmol/l

1.7

0.15

242

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

0.00

1.51

0.0

1.0

—

(3042733) HLA Ab [Presence] in Serum

2.87

1.50

2.2

4.6

—

(3004588) Protein electrophoresis panel - Serum or Plasma

700

1.30

1.50

2.8

1.5

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

1.96

1.49

2.3

1.8

u/field

1.1

1.3

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

147

1.65

1.48

1.4

—

(3020630) Protein [Mass/volume] in Serum or Plasma

102

821

1.27

1.44

2.8

1.6

g/l

65.9

66.7

0.55

738

(3044242) Glucose [Moles/volume] in Arterial blood

1.93

1.44

1.6

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

3.13

1.44

1.2

1.1

—

(3036048) Francisella tularensis Ab [Titer] in Serum

3.13

1.44

1.6

1.3

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

165

1.59

1.41

1.1

1.4

—

(3038515) Glucose [Moles/volume] in Venous blood

232

1.48

1.35

4.1

3.1

mmol/l

7.8

7.6

0.12

225

(3004775) Volume in Urine collected for unspecified duration

105

1.73

1.33

1.4

2.3

852.9

637.8

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

1.92

1.33

1.2

1.3

promille

2.0

1.2

—

(3021788) Differential panel - Synovial fluid

184

1.54

1.32

1.7

1.4

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

2.36

1.29

1.0

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

2.79

1.28

1.0

1.4

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

122

1.65

1.28

1.2

1.1

iu/ml

1.0

16.8

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

130

1.63

1.27

1.5

1.4

61.8

67.5

0.24

(3040151) Glucose [Moles/volume] in Capillary blood

138

1.61

1.27

5.4

7.2

mmol/l

7.7

7.9

0.11

111

(3019060) Gas panel - Arterial blood

727

1.26

4.9

4.7

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

709

1.26

1.2

1.3

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

657

1.27

1.23

4.7

4.0

ng/l

112.1

99.9

0.46

565

(3000012) Reticulocyte production index

1.97

1.22

1.1

1.6

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.64

1.21

3.0

1.2

—

(3018405) Lactate [Moles/volume] in Arterial blood

401

1.34

1.21

4.0

3.9

mmol/l

1.3

1.4

0.30

392

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

2.11

1.18

2.8

1.6

—

(3005570) Glucose [Moles/volume] in Urine

1.71

1.17

1.2

1.7

—

(3037522) Nuclear Ab [Titer] in Serum

112

936

1.22

1.17

1.2

1.3

titre

327.3

459.5

0.97

228

(3016750) Collection duration of Urine

1.82

1.15

1.4

2.0

min

538.6

493.0

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

709

1.25

1.15

7.3

6.8

mmol/l

24.2

24.6

0.32

660

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

196

0.56

1.13

1.1

1.2

—

3.0

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

208

0.57

1.12

1.1

1.2

—

50.6

—

(3047181) Lactate [Moles/volume] in Blood

328

1.36

1.12

5.3

6.1

mmol/l

1.3

0.27

293

(3024928) Oxygen saturation in Venous blood

227

1.42

1.09

5.2

3.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

341

1.33

1.04

1.3

1.4

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

510

1.27

1.04

4.7

3.7

48.5

47.7

0.09

501

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

1.96

1.03

3.3

3.7

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

150

0.53

1.03

1.4

1.3

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.07

1.03

2.0

2.4

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.07

1.03

2.0

2.4

—

(3039443) Prostate specific Ag panel - Serum or Plasma

214

0.60

1.02

1.5

1.7

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

123

1.55

1.00

1.2

1.3

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

215

1.41

0.98

5.8

3.7

mg/l

30.2

31.1

0.05

135

(3024471) HLA-A [Type]

2.18

0.98

1.0

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

124

1.54

0.97

4.1

3.3

57.3

58.7

0.14

124

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

1.95

0.97

1.6

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

1.95

0.97

1.6

1.2

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

1.81

0.96

1.1

—

(3019977) pH of Arterial blood

1.75

0.96

1.9

2.2

7.4

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

233

1.38

0.96

1.5

—

(3035880) pH of Pleural fluid

1.74

0.92

1.8

1.4

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

1.74

0.92

2.2

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

1.74

0.92

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

1.74

0.92

1.0

—

(3020876) Protein [Mass/time] in 24 hour Urine

1.67

0.91

1.9

—

1.4

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

1.64

0.91

2.4

1.2

u/ml

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

758

1.20

0.91

1.8

1.6

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

119

1.52

0.88

1.7

2.4

mg/l

13.2

20.4

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

1.79

0.88

1.0

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

2.01

0.87

10.8

2.0

—

(3023419) Bacteria identified in Sputum by Culture

153

1.45

0.86

1.6

2.4

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

291

1.32

0.85

1.3

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

120

1.51

0.85

3.7

3.1

e9/l

5.0

4.6

0.30

120

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

104

1.55

0.85

2.4

4.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

1.60

0.84

1.4

1.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

137

1.47

0.84

1.3

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

328

1.29

0.83

4.3

1.4

g/l

1.4

0.5

0.82

282

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

165

0.60

0.82

1.1

—

13.6

—

(4146454)

130

1.47

0.81

2.3

2.5

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

156

1.42

0.79

3.0

1.5

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

260

1.32

0.78

1.5

1.6

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

1.56

0.78

1.4

1.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

1.56

0.78

1.4

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

314

1.28

0.77

1.1

1.2

iu/ml

158.4

125.0

—

122

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

236

1.32

0.74

1.5

1.6

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

2.09

0.74

1.0

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

1.67

0.74

1.0

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

184

1.37

0.74

1.2

u/l

49.8

20.2

0.53

162

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

361

1.26

0.74

3.5

1.4

g/l

3.2

3.1

0.12

288

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

1.85

0.73

1.9

2.3

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

228

1.32

0.73

1.6

iu/ml

1.4

12.2

—

(3033799) Differential panel - Peritoneal fluid

2.00

0.72

2.0

1.8

—

(3004616) Nuclear Ab [Presence] in Serum

108

0.55

0.72

1.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

1.62

0.72

1.0

—

(44806420)

1.75

0.71

2.3

2.2

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

1.79

0.66

4.6

6.2

13.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

1.52

0.66

1.4

1.2

—

(3011648) Oxygen content in Venous blood

1.54

0.65

1.4

2.0

10.0

10.6

0.13

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

387

1.22

0.64

3.4

1.4

g/l

3.9

0.04

285

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

387

1.22

0.64

3.4

1.4

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

387

1.22

0.64

3.4

1.4

g/l

7.5

7.4

0.06

292

(3022689) Creatine [Moles/volume] in Urine

1.73

0.64

2.0

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

1.50

0.63

1.4

1.2

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

1.50

0.63

1.4

1.2

—

(3004451) EKG impression Narrative

1.60

0.61

1.9

1.4

—

(3000285) Sodium [Moles/volume] in Blood

0.00

0.60

0.0

1.1

—

(3017569) Oxygen content in Arterial blood

1.53

0.59

1.8

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

241

0.74

0.57

1.4

1.5

—

(3000475) Leukocytes [#/volume] in Synovial fluid

267

1.24

0.54

1.7

1.6

e6/l

13948.3

16790.5

0.24

195

(4015189)

1.58

0.54

2.2

1.8

—

(3017704) Immunofixation for Urine

1.48

0.53

1.0

1.3

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.47

0.50

1.2

—

(3020891) Body temperature

437

1.18

0.49

5.1

4.8

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

189

0.74

0.48

1.9

1.3

e6/l

1310.7

856.4

—

159

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

189

0.74

0.48

1.8

1.3

e6/l

18.9

47.2

—

156

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.53

0.48

1.0

—

(3011288) Drugs identified in Urine by Screen method

1.53

0.48

1.0

2.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

376

0.82

0.48

2.0

1.9

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

1.49

0.47

1.6

1.2

—

(3007164) IgA [Mass/volume] in Serum or Plasma

136

1249

1.10

0.47

1.6

1.3

g/l

3.2

3.0

0.21

728

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

1.46

0.47

1.6

1.2

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

365

1.19

0.46

3.7

1.4

g/l

10.3

10.9

0.44

310

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

191

1.26

0.46

1.5

1.7

mg/l

10.4

12.4

0.40

174

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

1.43

0.46

2.6

2.4

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

174

1.27

0.45

1.3

1.2

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

256

1.22

0.44

1.2

—

8.0

—

(3043409) Potassium [Moles/volume] in Arterial blood

339

1.19

0.44

4.8

4.3

mmol/l

4.0

0.11

309

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

186

0.75

0.44

1.4

1.2

mmol/l

4.1

4.0

0.11

168

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

1.45

0.44

1.0

1.2

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

1.62

0.43

1.0

1.7

u/ml

620.6

965.0

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1.43

0.42

1.5

1.4

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

217

0.78

0.41

1.3

1.2

mg/l

791.3

509.2

0.68

198

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

250

0.80

0.41

1.8

1.7

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1.38

0.41

1.8

2.6

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

0.00

0.40

0.0

1.1

—

(3003129) Base excess in Capillary blood by calculation

1.47

0.40

2.8

1.4

mmol/l

-0.3

0.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

1.47

0.40

1.4

3.4

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

1.43

0.39

1.0

1.1

u/ml

—

24.8

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

317

1.17

0.38

1.4

1.7

u/l

36.6

38.5

0.25

258

(21494434) Karyotype in Bone marrow

1.35

0.38

1.2

1.1

—

(4062490)

1.31

0.37

1.8

1.2

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.35

0.37

1.0

1.2

—

(3034770) Mitochondria Ab [Titer] in Serum

213

0.79

0.37

1.1

—

1355.0

—

(3044290) Cell count panel - Cerebral spinal fluid

168

0.77

0.36

1.8

1.2

—

(21494755) Public health laboratory ask at order entry panel

287

0.83

0.35

1.4

—

(3003327) Ova and parasites identified in Stool by Light microscopy

199

0.80

0.33

1.4

1.7

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

1.31

0.33

1.3

1.8

—

(3023183) Ammonium ion [Moles/volume] in Plasma

220

0.82

0.32

1.3

2.8

umol/l

24.4

37.4

2.12

189

(3048929) Epstein Barr virus Ab [Presence] in Serum

155

1.23

0.32

1.2

—

(3044927) Protein electrophoresis panel - Urine

128

1.25

0.32

1.1

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

1.31

0.32

1.3

1.2

nmol/l

1.2

1.5

0.63

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

260

0.84

0.29

1.1

1.0

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

1.23

0.29

1.1

mmol/l

2.3

2.0

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

112

1.25

0.28

1.1

1.2

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

289

1.15

0.28

4.4

1.4

g/l

0.4

0.1

0.60

268

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

1.28

0.28

1.2

1.4

14.7

20.9

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

1.27

0.27

1.3

1.2

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

1.27

0.27

1.0

1.1

nmol/l

—

11.5

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

122

1.23

0.27

1.2

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

128

0.78

0.27

1.2

1.7

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

113

1.24

0.26

1.1

1.2

u/ml

282.6

295.9

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

104

1.25

0.26

1.3

u/ml

105.7

101.7

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

311

1.13

0.25

4.2

1.4

g/l

35.3

37.2

0.93

264

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

1.17

0.24

1.0

1.4

—

200.0

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

1.28

0.23

1.4

pmol/l

83.6

69.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

1.25

0.22

2.6

1.3

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

1.22

0.22

1.0

1.3

u/l

—

11.2

—

(3047189) Immunofixation for 24 hour Urine

1.22

0.22

1.8

1.1

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

0.00

0.21

0.0

1.7

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.00

0.21

0.0

1.4

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.00

0.21

0.0

5.0

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

1.2

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

107

1014

1.06

0.21

3.7

3.1

ng/l

319.2

249.7

0.71

100

953

(44790049)

1.23

0.21

2.1

1.4

—

(44790047)

1.23

0.21

2.1

1.4

—

(44790048)

1.23

0.21

2.1

1.4

—

(44806118)

1.23

0.21

2.1

1.4

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.00

0.21

0.0

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.00

0.21

0.0

2.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

154

1.17

0.21

1.3

1.4

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.7

—

15.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

1.25

0.20

1.1

1.3

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

0.00

0.20

0.0

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

144

0.83

0.20

1.2

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

127

1.18

0.19

1.3

—

23.3

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

146

1403

1.05

0.18

1.2

u/ml

2.1

1.7

0.13

376

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

272

1.11

0.17

4.7

1.4

g/l

0.0

0.00

251

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

215

0.88

0.17

1.1

1.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

476

1.07

0.16

1.1

1.3

—

(4094501)

246

0.89

0.16

1.0

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

1.14

0.16

3.1

12.9

—

(3016018) Differential panel - Cerebral spinal fluid

1.14

0.15

1.9

1.1

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

267

1.09

0.13

1.2

1.1

—

1.0

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

133

1289

1.04

0.12

8.0

7.3

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

200

0.90

0.12

1.4

1.3

nmol/l

1.2

0.8

0.95

164

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

124

1.13

0.11

1.4

1.3

—

(42529406) Shigella sp [Presence] in Stool by Culture

219

0.91

0.11

1.1

1.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

1.16

0.11

1.1

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

112

1153

0.97

0.10

1.2

u/ml

6.0

12.3

0.93

399

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

121

1178

1.03

0.09

1.2

1.3

iu/ml

24.1

39.1

1.16

341

(3014765) Yersinia sp identified in Stool by Organism specific culture

217

0.92

0.09

1.1

1.2

—

(3006462) Nitrate [Presence] in Urine

1.04

0.09

3.8

3.3

—

(3000093) Morphology [Interpretation] in Blood Narrative

1.14

0.09

1.2

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

1.14

0.09

1.5

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

1.11

0.09

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

1.11

0.09

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

1.11

0.09

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

1.07

0.08

1.2

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

1.07

0.08

1.0

1.3

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

1.07

0.08

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

1.07

0.08

1.2

1.1

—

(3044941) Cell count panel - Synovial fluid

175

1.09

0.08

1.8

1.4

—

(4268621)

0.82

0.08

2.8

2.3

—

(3024263) Appearance of Synovial fluid

0.78

0.08

1.4

1.8

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

1.05

0.08

1.0

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

824

0.97

0.08

1.5

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1.07

0.07

1.1

1.4

—

(3023410) Appearance of Cerebral spinal fluid

0.86

0.07

2.0

1.2

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

0.85

0.07

1.7

1.3

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

255

0.94

0.07

1.3

1.8

nmol/l

43.0

45.1

0.19

237

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1.03

0.07

1.1

—

(4306422)

1.12

0.07

1.4

1.2

—

(36660697) Celiac disease serology panel - Serum

502

1.04

0.06

1.2

1.1

—

(3048689) Calprotectin [Mass/mass] in Stool

711

1.03

0.06

2.3

2.2

ug/g

155.4

180.7

0.23

545

(3004716) Salmonella sp identified in Stool by Organism specific culture

274

0.95

0.06

1.1

1.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

251

0.96

0.04

1.2

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

180

0.94

0.04

1.5

1.6

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

111

1.08

0.04

1.4

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

121

1.08

0.03

1.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

108

0.93

0.03

1.1

1.0

g/l

1.3

1.6

—

(4010399)

670

1.02

0.02

1.5

1.4

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

116

0.95

0.00

1.0

—

(3025941) Bacteria identified in Stool by Culture

374

1.02

0.00

1.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

244

0.98

0.00

1.3

1.4

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

118

1.02

0.00

1.0

1.1

—

(3008898) HLA-B27 [Presence]

151

0.99

0.00

1.0

1.1

—

(1002224) Polysomnography panel

209

1.00

0.00

1.0

1.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

768

1.00

0.00

1.2

1.7

0.19

639

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

165

0.97

0.00

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

0.00

0.0

1.2

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

0.91

0.00

1.2

1.1

—

(3019174) dRVVT (LA screen)

0.00

0.0

1.2

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

0.00

0.0

1.1

—

(3016879) Cocaine [Presence] in Urine

0.95

0.00

1.0

1.6

—

(3001729) Color of Synovial fluid

0.00

0.0

1.6

—

(3016038) Potassium [Moles/volume] in Urine

0.94

0.00

1.0

1.2

mmol/l

30.3

34.5

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.3

—

17.4

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.0

1.2

—

1.0

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

0.00

0.0

1.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

0.00

0.0

1.0

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.0

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

1.01

0.00

2.3

1.3

—

(3045462) Protein/Creatinine [Ratio] in Urine

0.00

0.0

6.6

—

21.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

0.00

0.0

1.0

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.00

0.0

1.3

—

421.6

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.00

0.0

1.0

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

0.0

1.7

—

(4211845)

0.93

0.00

3.8

3.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

0.00

0.0

1.0

—

(3032773) Endomysium IgG Ab [Titer] in Serum

0.93

0.00

1.0

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

0.00

0.0

1.0

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.0

1.0

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

0.85

0.00

1.0

1.3

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

0.00

0.0

1.4

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

0.00

0.0

1.0

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.4

—

(3028300) Cannabinoids [Presence] in Urine

0.91

0.00

1.0

1.5

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

0.00

0.0

1.5

—

9.3

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

0.00

0.0

1.5

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

0.92

0.00

1.8

1.3

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.00

0.0

1.2

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

0.00

0.0

1.2

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

0.95

0.00

1.2

1.1

—

(40757494) Bilirubin.total [Moles/volume] in Blood

0.94

0.00

2.0

1.7

—

21.3

—

(3000764) Benzodiazepines [Presence] in Urine

0.93

0.00

1.0

1.6

—

(3013762) Body weight Measured

0.00

0.0

1.6

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

0.94

0.00

1.4

1.7

—

2064.0

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

0.00

0.0

1.8

—

(3045716) Anion gap in Serum or Plasma

1.00

0.00

1.5

1.8

mmol/l

10.7

10.1

—

(3027944) Amphetamines [Presence] in Urine

0.92

0.00

1.0

1.5

—

(3027008) Opiates [Presence] in Urine

0.91

0.00

1.0

1.5

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

0.92

0.00

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

0.0

2.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint CD2_INSITU_BLADDER_EXALLC and mortality.

Females

Parameter	HR [95% CI]	p-value
CD2_INSITU_BLADDER_EXALLC	1.104 [0.82, 1.49]	0.513
Birth year	0.999 [0.99, 1.01]	0.751

During the follow-up period (1.1.1998 — 31.12.2019), 123 out of 763 females with CD2_INSITU_BLADDER_EXALLC died.

Males

Parameter	HR [95% CI]	p-value
CD2_INSITU_BLADDER_EXALLC	0.965 [0.79, 1.18]	0.735
Birth year	0.985 [0.98, 0.99]	0.002

During the follow-up period (1.1.1998 — 31.12.2019), 517 out of 3037 males with CD2_INSITU_BLADDER_EXALLC died.

Mortality risk

Mortality risk for people of age

years, who have CD2_INSITU_BLADDER_EXALLC.

N-year risk	Females	Males
1	0.147%	0.173%
5	0.776%	0.998%
10	1.886%	2.552%
15	3.643%	4.903%
20	6.21%	8.331%

Relationships between endpoints

↥

Index endpoint: CD2_INSITU_BLADDER_EXALLC – Carcinoma in situ, bladder

GWS hits: 2

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Carcinoma in situ, bladder

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints